Edition:
United States

People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

40.12USD
14 Jun 2019
Change (% chg)

$-0.01 (-0.02%)
Prev Close
$40.13
Open
$39.95
Day's High
$40.15
Day's Low
$39.92
Volume
1,836,589
Avg. Vol
2,498,224
52-wk High
$42.32
52-wk Low
$36.41

Miels, Luke 

Mr. Luke Miels is the President - Global Pharmaceuticals of the Company. Luke joined GSK and CET in September 2017 as President, Global Pharmaceuticals responsible for our commercial portfolio of medicines and vaccines. Previously, he worked for AstraZeneca as Executive Vice President of their European business and, prior to that, Executive Vice President of Global Product and Portfolio Strategy, Global Medical Affairs and Corporate Affairs. Before then, he held roles of increasing seniority at Roche and Sanofi-Aventis. He holds a Bachelor of Science degree in Biology from Flinders University in Adelaide and an MBA from the Macquarie University, Sydney.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --